ABSTRACT

Background: Interstitial lung disease (ILD) is a heterogeneous group of diseases that affects pulmonary interstitium. Material and methods: An observational, retrospective and descriptive study was conducted in patients discharged from January 2010 to June 2015, with the codes ICD-10: (J67) hypersensitivity pneumonitis, (J82) eosinophilia unclassified, (J84) other interstitial lung diseases, and the different numerals available for each of them. To evaluate if clinical diagnosis reported in the interstitial lung diseases service were similar to ICD coding used. Results: We included 1,279 patients, classifying them according to the physician’s diagnosis, the most common diseases reported was: ILD 538 (42%), HP 223 (17.4%), IPF 185 (14.4%), unclassifiable pulmonary fibrosis (UPF) 155 (12.1%) and NSIP 95 (7.4%), while the ICD-10 grouped them indistinctly. Conclusion: The results obtained in this study corroborated that ICD-10 code using in ILD is insufficient for all the diagnoses included in this group so it is necessary unify the codes to perform epidemiological studies in the future.

KEYWORDS

ICD-10, interstitial lung disease, coding.

REFERENCES

1. Marcos PJ, Montero C, Otéro GI. Una mirada general a las enfermedades pulmonares intersticiales y una específica a la fibrosis pulmonar idiopática. Galicia Clin 2013;74(1):13-22.

2. Ley B, Collard HR. Epidemiology of idiopathic pulmonary fibrosis. Clin Epidemiol 2013;5:483-492. doi 10.2147/CLEP. S54815.

3. Selman M, Pardo A, King TE Jr. Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med 2012;186(4):314-324. doi: 10.1164/rccm.201203-0513CI.

4. Martínez-Briseño D, García-Sancho C, Fernández-Plata R, Franco-Marina F, Torre-Bouscoulet L, Pérez-Padilla R. Tendencia de la mortalidad por enfermedades intersticiales en México, período 2000-2010. Neumol Cir Torax 2014;73(3):179-184.

5. Pérez-Dórame R, Mejía M, Mateos-Toledo H, Rojas-Serrano J. Rheumatoid arthritis-associated interstitial lung disease: lung inflammation evaluated with high resolution computed tomography scan is correlated to rheumatoid arthritis disease activity. Reumatol Clin 2015;11(1):12-16. doi: 10.1016/j.reuma.2014.02.007.

6. Rojas-Serrano J, González-Velásquez E, Mejía M, Sánchez-Rodríguez A, Carrillo G. Interstitial lung disease related to rheumatoid arthritis: evolution after treatment. Reumatol Clin 2012;8(2):68-71. doi: 10.1016/j.reuma.2011.12.008.

7. WHO. Classifications. International classification of diseases (ICD). Anexo: CIE-10. Enfermedades del sistema respiratorio. Fecha de consulta: 29-06-2014. Accesible en: www.who.int/whosis/icd10/

8. International Statistical Classification of Diseases and Related Health Problems. 10th Revision. Accessible en: www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf

9. Travis WD, Costabel U, Hansell DM, et al.; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188(6):733-748. doi: 10.1164/rccm.201308-1483ST.

10. Sgalla G, Biffi A, Richeldi L. Idiopathic pulmonary fibrosis: diagnosis, epidemiology and natural history. Respirology 2016;21(3):427-437. doi: 10.1111/resp.12683.

11. Oldham JM, Adegunsoye A, Valenzi E, et al. Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J 2016;47(6):1767-1775. doi: 10.1183/13993003.01565-2015.

12. Fischer A, Antoniou KM, Brown KK, et al.; ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015;46(4):976-987. doi: 10.1183/13993003.00150-2015.